Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
Curr Pharm Des. 2011;17(25):2603-12. doi: 10.2174/138161211797416093.
Curr Pharm Des. 2011.
PMID: 21728979
Review.